arrow
K

Karim Lakhal

chu de nantes
H指数:33
被引数:3,939

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of Standard Meropenem Dosing in Healthcare-Associated Meningitis: Is It Universal?

美罗培南标准剂量在医疗相关性脑膜炎中的疗效:是否普遍适用?

2026-10-060
OAAI
CSF pharmacokinetics-pharmacodynamics of linezolid in critically brain injured patients, with or without central nervous system healthcare-associated infection. The PK-Pop-LCR Study: A Multicenter Pharmacokinetics and Pharmacodynamics Population Study.

重症脑损伤患者中利奈唑胺的脑脊液药代动力学-药效学研究,伴有或不伴有中枢神经系统医院相关性感染。PK-Pop-LCR研究:一项多中心药代动力学和药效学群体研究。

2026-08-170
PRE
Cost-utility of point-of-care viscoelastic hemostatic assays in the management of bleeding during cardiac surgery: a single-blinded prospective multicenter stepped wedge cluster randomized trial in French context

心脏手术中床旁粘弹性止血功能检测的成本-效用分析:一项在法国背景下进行的单盲前瞻性多中心阶梯式整群随机试验

2025-11-200
OAAI
Weaning from external ventricular drainage after non-traumatic subarachnoid hemorrhage: Rapid vs. gradual weaning and predicting closure trial failure. The SEVDVE retrospective multicenter cohort study

非创伤性蛛网膜下腔出血后停止脑室外引流:快速与逐渐停止及预测关闭试验失败。SEVDVE回顾性多中心队列研究

2025-05-010
OAAI
Clinical evaluation of the BioFire Respiratory Pathogen Panel for the guidance of empirical antimicrobial therapy in critically ill patients with hospital-acquired pneumonia: A multicenter, quality improvement project
2024-04-012
PRE
Renal replacement therapy initiation strategies in comatose patients with severe acute kidney injury: a secondary analysis of a multicenter randomized controlled trial

严重急性肾损伤昏迷患者的肾脏替代治疗启动策略: 一项多中心随机对照试验的二次分析

2024-02-262
PRE